Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Regional Health Authorities to Meet and Discuss Russia’s 2020 Vision

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
Government aims for 50% of sold drugs to be manufactured in Russia by 2020.

The Russian pharmaceutical market is one of the fastest growing in the world. Its value is predicted to rise from $24 billion in 2012 to $75 billion by 2020, according to Cegedim Relationship Management’s aggregated opinion from industry experts, government employees and analysts.

The pharma 2020 strategy proposed by the government, which aims for 50% of sold drugs to be manufactured in Russia by 2020 – has encouraged many multinational organizations to locate manufacturing in Russia. However, there are some crucial structural defects in this market, such as complex administrative procedures and insufficient international cooperation, which tend to inhibit its full development. Foreign companies continue to face challenges surrounding government regulations and unclear requirements to achieve GMP, while local manufacturers grapple with limited capabilities and technical know-how.

In an effort to take Russia a step closer towards achieving its 2020 pharma vision, representatives from the Ministry of Ukraine, RIBS Kazakhstan, and other regional health authorities will gather on 7-8 November 2013 at Vaccine World CIS and CEE 2013 to help local manufacturers by equipping them with the required technical know-how, and helping them overcome challenges relating to manufacturing and R&D, and regulatory controls. International players will also have the chance to meet and build relationships/ forge partnerships with local manufacturers.

Over 25 vaccine industry experts will come together to share information on topics like the vaccine market overview, Russia’s 2020 vision, innovative approaches and best practices to vaccine manufacturing, manufacturing excellence and quality assurance, next generation vaccine development, vaccine technology, and partnerships.

The list of speakers and advisors that will participating at this gathering include:

•    Kim Bush, Director, Life Sciences Partnerships, Global Health Program, Bill & Melinda Gates Foundation
•    Dr. Yurii Gamazin, Senior Advisor to the Director General, Ukrainian State Expert Center, Ukraine
•    Natalia Puchkova, First Deputy General Director, Petrovax Pharm, Russia
•    Berik Khairullin, Deputy General Director, RIBS, Kazakhstan
•    Ugo D’Oro, Head of Unit in the Immunology Function, Novartis Vaccines Research, Italy
•    Alexander Ivanov, Research Scientist, Microgen Holding
•    iviana Teresa Sara Gianninò, Researcher and Project Leader, Etna Biotech s.r.l., Catania – Zydus Cadila Research Center (Cadila Healthcare, Ahmedabad - India)
•    Peter Keller, Chief Business Officer, Selecta Biosciences
•    S.D. Ravetkar, Executive Director, Serum Institute of India Ltd, India
•    Werner Cautreels, CEO, Selecta Biosciences, USA
•    Nikolai Petrovsky, Chairman, Vaxine, Australia
•    Sergey Dudkin, Director, Strategy and Development, NewVac LLC, Russia
•    Jiri Hermanek, CEO, Sotio, Russia
•    Sayadyan Khachik, CEO, ABIOLEK & Chief of Science and Development, NT Pharma, Russia
•    Jeffrey Ulmer, Global Head, External Research Novartis, USA
•    Boro Dropulic, President and Chief Scientific Officer, Lentigen Corporation, USA
•    Kateryna Gamazina, Country Director, PATH
•    Igor Orshanskiy, CEO, NewVac, Russia


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

IMAPAC to Bring Together Over 150 Leading Industry Players
IMAPAC’s 3rd Biologics Korea gathering from 22-24 April 2014 in Seoul, Korea.
Wednesday, February 19, 2014
Top Biologic Industry Leaders to Convene at Biologics World Korea 2013
Bringing together biologics drug innovators and bioprocess professionals from all around the world to discuss strategies in biosimilar and biobetter development, as well as cutting-edge advances in bioprocessing and bioanalytics.
Friday, December 07, 2012
Last Days of the Early Bird Pricings for Biologics World China 2012
Keep up to date with China’s changing biopharma landscape by registering for Biologics World China 2012.
Monday, September 24, 2012
Scientific News
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Cancer Discovery Links Experimental Vaccine and Biological Treatment
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Study Reveals New Method to Develop More Efficient Drugs
A new study suggests a new approach to develop highly-potent drugs which could overcome current shortcomings of low drug efficacy and multi-drug resistance in the treatment of cancer as well as viral and bacterial infections.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!